CITEST DIAGNOSTICS INC.
This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
CITEST DIAGNOSTICS INC.
High-quality COVID-19 Antigen & Antibody Tests, Women’s Health, Infectious Disease, Drug Abuse, and more. ISO13485 certified, FDA-cleared, CE-marked. Trusted by healthcare providers worldwide.
CITEST DIAGNOSTICS INC., an emerging In Vitro Diagnostics company based in Canada, is experiencing growth on a global scale, engaging in multinational operations. Founded by highly experienced IVD industry professionals with proven track records, we are committed to innovation, quality, and reliability.
Our IVD products are manufactured in ISO13485:2016 accredited facilities under strict quality assurance systems. Using industry-leading design control, we ensure consistent performance and accuracy across all our rapid test kits.
We focus on high-performance rapid diagnostic solutions for global health challenges.
Fast, accurate detection of SARS-CoV-2 antigens.
Detect IgG/IgM antibodies post-infection or vaccination.
Including GBS, Trichomonas, and fertility tests.
Zika, Dengue, Influenza, and more.
Multi-panel urine drug screening with FDA OTC clearance.
Early detection support for cancer markers.
Rapid assessment for heart conditions.
Animal health diagnostics for clinics and farms.
Trusted by healthcare professionals worldwide. All kits are CE, FDA, or ISO certified.
Nasal swab, CE-marked, self-testing use. Dual detection in 15 minutes.
Vaginal swab, 10T format, women’s health diagnostic.
Qualitative detection for Group B Streptococcus in prenatal screening.
Urine specimen, detects SSRIs, used in drug abuse screening.
Whole blood, serum, or plasma. Rapid presumptive diagnosis.
Fast results, card format, ideal for emergency and field use.
CE & FDA rapid screening, 5-minute results, OTC use.
100ng/mL cutoff, 95.9% accuracy, single drug detection.
ISO13485:2016 certified manufacturing. CE, FDA OTC cleared, and WHO-compliant.
Most tests deliver results in 5–15 minutes. Ideal for point-of-care and field use.
Products sold in over 100 countries. Multilingual support and global logistics.
Yes, several of our Drug of Abuse (DOA) rapid tests have received US FDA OTC clearance. Our COVID-19 antigen tests are CE marked and included in official white lists.
Yes, we provide comprehensive OEM and ODM services including custom packaging, branding, and formulation adjustments based on client requirements.
MOQ varies by product. For most rapid test cassettes, it starts at 1,000 units. Contact us for specific product quotes.
Yes, we offer sample kits for evaluation. Please contact us with your requirements and shipping address.
Yes, our product documentation is available in English, Spanish, French, Arabic, Persian, Russian, and more.
For quotes, samples, or partnership opportunities, visit our official website to contact CITEST Diagnostics Inc.
Email: [email protected]
Phone: +86 15700175322
Address: 170-422 Richards Street, Vancouver BC V6B 2Z4, CANADA
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact [email protected]
如果您是其他域名合作 也请联系[email protected]